Therapy areas
Enter at least 3 characters

HOME > Therapy Areas

Respiratory

Chiesi has been developing medicines to treat respiratory disease for more than 30 years, including therapies for asthma and chronic obstructive pulmonary disease (COPD). 

Neonatology

Chiesi has been deeply committed to Neonatology for over 30 years. Working alongside the medical community and investing in Neonatal Research & Development, Chiesi has the ultimate mission to offer innovative and effective treatment options to improve the level of care for preterm babies. Thanks to this continuous commitment and working towards the sharing of best clinical practices, Chiesi has become a global partner for neonatologists, bringing its life-saving medicinal products to nearly 100 countries worldwide.

Rare Diseases

In 2020, Chiesi launched Chiesi Global Rare Diseases, a business unit focused on supporting people living with rare diseases. The Global Rare Diseases unit works in collaboration with the wider Chiesi Group to harness the full resources and capabilities of our global network.  Our goal is to support as many people as possible living with rare diseases, so that they can lead the lives they want. We collaborate with the rare disease community to bring the voices of those affected to the fore.

Transplantation

Transplantation is a therapy area to which Chiesi are fully committed.

Other Disease Areas

Chiesi has developed a range of medicines across a number of therapy areas including rheumatoid arthritis (RA), osteoarthritis, ankylosing spondylitis (AS) and cardiovascular disease.

UK-CHI-2400095 January 2024

© 2025 Chiesi Limited
333 Styal Road Manchester M22 5LG
Registered in England and Wales No. 2140985. VAT Registration No. GB686750782
CHIESI ON THE WEB
FOLLOW US ON:
Details of Chiesi’s clinical trials can be found at www.clinicaltrials.gov
-